Scientists studying why some large, long-lived animals rarely develop cancer have found an intriguing clue in the bowhead whale. Published in Nature, the work adds to comparative oncology and addresses Peto’s paradox: despite having many cells and long lifespans, animals like whales and elephants show surprisingly low rates of malignant tumors, implying they evolved extra cancer defenses.
Previous studies showed elephants rely on extra copies of a tumor suppressor gene that produces p53, a protein that prompts death of damaged cells. The bowhead whale, which can live more than 200 years, appears to take a different approach. Vera Gorbunova and colleagues obtained small tissue samples from Iñupiaq hunters in Barrow, Alaska, and found that bowhead cells are unusually good at repairing DNA damage. In lab assays, bowhead cells repaired broken DNA roughly two to three times better than human cells.
The team traced this enhanced repair to high levels of a protein called CIRBP, short for cold-inducible RNA-binding protein. CIRBP is produced abundantly in bowhead tissues and its gene is known to respond to cold, consistent with the whales’ Arctic environment. Rather than primarily eliminating damaged cells, bowheads seem to invest in maintenance: repairing DNA to preserve cell health over centuries.
To assess whether CIRBP can affect other species, researchers raised CIRBP levels in human cells and in fruit flies. Human cells engineered to overproduce CIRBP repaired DNA breaks more efficiently. Fruit flies that made extra CIRBP lived longer and tolerated DNA damage better. Those experiments suggest CIRBP can strengthen genome maintenance across diverse organisms and point to potential strategies to slow mutation accumulation.
Experts caution against assuming a simple path to human therapies. Evolutionary solutions often involve trade-offs, such as energetic costs or other physiological consequences, and what works in a whale or fly may not translate safely to humans. Comparative biologists also note many different mechanisms likely contribute to cancer resistance across species, with bats, naked mole rats, and elephants each offering distinct clues. Preserving biodiversity is therefore important because unique biological strategies may be lost if species go extinct.
The study also highlights ethical and collaborative aspects of this research. Working with Indigenous communities was essential for obtaining samples respectfully, and the authors emphasize hope that the work could one day benefit communities such as the Iñupiaq, who face rising cancer rates.
Overall, the findings suggest an alternative route to cancer resistance: instead of increasing elimination of damaged cells, some long-lived species may emphasize superior DNA repair to maintain genome integrity. The discovery of CIRBP’s role opens new avenues for research into whether enhancing similar pathways in humans could reduce mutation accumulation and lower cancer risk, while underscoring the scientific and practical challenges ahead.